logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Improving access to liposomal amphotericin B worldwide – Authors’ reply

Lee JSF, Sued O, Ribeiro I, Jarvis JN, Burry J
2025-01-01 • Lancet Global Health
2025-01-01 • Lancet Global Health
Journal Article
|
Letter

The long wait for long-acting HIV prevention and treatment formulations

Venter WDF, Gandhi M, Sokhela S, Sikwese K, Bygrave H,  et al.
2024-10-01 • Lancet HIV
2024-10-01 • Lancet HIV
Journal Article
|
Review

Paving the way for affordable and equitable liposomal amphotericin B access worldwide

Lee JSF, Cohen RM, Khan RA, Burry J, Casas EC,  et al.
2024-09-01 • Lancet Global Health
2024-09-01 • Lancet Global Health
Journal Article
|
Commentary

Access to medicines for treating people With cryptococcal meningitis

Burry J, Casas CP, Ford NP
2022-08-29 • Clinical Infectious Diseases
2022-08-29 • Clinical Infectious Diseases
Cryptococcal meningitis accounts for 1 in 5 AIDS-related deaths globally. World Health Organization guidelines strongly recommend a single high dose of liposomal amphotericin B as part o...
Journal Article
|
Review

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry J,  et al.
2019-02-01 • Lancet Gastroenterology and Hepatology
2019-02-01 • Lancet Gastroenterology and Hepatology
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual mortality from viral hepatitis is similar to that of other major infectious diseases such a...
Journal Article
|
Commentary

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Loyse A, Burry J, Cohn J, Ford NP, Chiller T,  et al.
2018-10-18 • Lancet Infectious Diseases
2018-10-18 • Lancet Infectious Diseases
In 2018, WHO issued guidelines for the diagnosis, prevention, and management of HIV-related cryptococcal disease. Two strategies are recommended to reduce the high mortality associated w...
Journal Article
|
Review

Strategies for access to affordable hepatitis C testing and treatment in Asia

Khwairakpam G, Burry J
2019-01-01 • Current Opinion in HIV and AIDS
2019-01-01 • Current Opinion in HIV and AIDS
With increasing availability of generic direct-acting antivirals (DAAs) and associated price reductions, various governments, multilateral institutions, and donors have started providing...
Journal Article
|
Commentary

Cryptococcal meningitis: A neglected NTD?

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP,  et al.
2017-06-29 • PLOS Neglected Tropical Diseases
2017-06-29 • PLOS Neglected Tropical Diseases